Laboratory markers of osteosarcopenic obesity

Q3 Medicine

Russian Journal of Cardiology Pub Date : 2023-12-20 DOI:10.15829/1560-4071-2023-5563

O. V. Gritsenko, O. Gruzdeva, G. A. Chumakova, O. Barbarash

引用次数: 0

Abstract

Osteosarcopenic obesity syndrome involves the simultaneous deterioration of bone, muscle, and excess fat accumulation, resulting in systemic metabolic dysregulation. Currently, the relevance of this problem is increasing due to the global population aging, the high incidence of obesity, type 2 diabetes, sarcopenia and frailty in developed countries of the modern world. In this regard, novel diagnosis methods for this condition, including laboratory markers, should be developed. The review examines modern biomarkers of osteosarcopenic obesity.

查看原文本刊更多论文

骨质疏松性肥胖症的实验室指标

骨肉疏松性肥胖综合症是指骨骼、肌肉同时退化，脂肪堆积过多，导致全身代谢失调。目前，由于全球人口老龄化，现代发达国家肥胖症、2 型糖尿病、肌肉疏松症和虚弱症的发病率居高不下，这一问题的相关性日益增加。为此，应开发新的诊断方法，包括实验室标志物。本综述探讨了骨质疏松性肥胖症的现代生物标志物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Russian Journal of Cardiology Medicine-Cardiology and Cardiovascular Medicine

CiteScore

2.20

自引率

0.00%

发文量

185

审稿时长

1 months

期刊介绍： Russian Journal of Cardiology has been issued since 1996. The language of this publication is Russian, with tables of contents and abstracts of all articles presented in English as well. Editor-in-Chief: Prof. Eugene V.Shlyakhto, President of the Russian Society of Cardiology. The aim of the journal is both scientific and practical, also with referring to organizing matters of the Society. The best of all cardiologic research in Russia is submitted to the Journal. Moreover, it contains useful tips and clinical examples for practicing cardiologists. Journal is peer-reviewed, with multi-stage editing. The editorial board is presented by the leading cardiologists from different cities of Russia.